000710.SZ SHZ
Berry Genomics Co.,Ltd
1W: +14.2%
1M: +21.9%
3M: +38.5%
YTD: -14.4%
1Y: -26.5%
3Y: -1.8%
5Y: -64.1%
¥10.87 ($1.62)
+0.99 (+10.02%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Balance Sheet Trends
Total Assets
$2.4B
-13.0% ▼
5Y CAGR: -4.9%
Total Liabilities
$670M
-20.9% ▼
5Y CAGR: -1.5%
Shareholders Equity
$1.7B
-9.9% ▼
5Y CAGR: -6.3%
Cash & Investments
$400M
+13.7% ▲
5Y CAGR: -0.9%
Total Debt
$157M
-36.9% ▼
5Y CAGR: -9.4%
Net Debt
-$226M
-554.9% ▼
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $629M | $418M | $334M | $338M | $383M |
| Short-Term Investments | $4M | $4M | $5M | $14M | $17M |
| Cash & ST Investments | $633M | $422M | $338M | $352M | $400M |
| Net Receivables | $1.1B | $1.1B | $1.1B | $815M | $771M |
| Inventory | $180M | $234M | $231M | $229M | $195M |
| Other Current Assets | $127M | $146M | $99M | $76M | $61M |
| Total Current Assets | $2.0B | $1.9B | $1.7B | $1.5B | $1.4B |
| Property, Plant & Equip. | $909M | $1.1B | $1.1B | $923M | $459M |
| Goodwill & Intangibles | $84M | $87M | $91M | $104M | $75M |
| Long-Term Investments | $163M | $275M | $134M | $35M | $160M |
| Other Non-Current Assets | $53M | $56M | $46M | $55M | $107M |
| Total Non-Current Assets | $1.2B | $1.6B | $1.5B | $1.3B | $946M |
| Total Assets | $3.2B | $3.5B | $3.2B | $2.7B | $2.4B |
| — Liabilities — | |||||
| Accounts Payable | $243M | $340M | $164M | $277M | $288M |
| Short-Term Debt | $123M | $191M | $204M | $203M | $113M |
| Deferred Revenue | $187M | $222M | $104M | $0 | $0 |
| Other Current Liabilities | $74M | $16M | $242M | $268M | $115M |
| Total Current Liabilities | $556M | $769M | $705M | $763M | $591M |
| Long-Term Debt | $236M | $186M | $127M | $42M | $0 |
| Other Non-Current Liab. | -$24M | $4M | $12M | $0 | $0 |
| Total Non-Current Liabilities | $265M | $227M | $167M | $83M | $79M |
| Total Liabilities | $822M | $996M | $872M | $847M | $670M |
| — Equity — | |||||
| Common Stock | $355M | $355M | $355M | $354M | $354M |
| Retained Earnings | $1.1B | $942M | $684M | $257M | $65M |
| Accumulated OCI | $260M | $416M | $486M | $17M | $440M |
| Total Stockholders Equity | $2.4B | $2.5B | $2.3B | $1.9B | $1.7B |
| Total Liabilities & Equity | $3.2B | $3.5B | $3.2B | $2.7B | $2.4B |
| — Key Metrics — | |||||
| Total Debt | $360M | $399M | $348M | $248M | $157M |
| Net Debt | -$269M | -$19M | $15M | -$35M | -$226M |
| Total Investments | $167M | $279M | $138M | $48M | $177M |